Home › Mesothelioma › Washington
Mesothelioma clinical trials in Washington, DC
9 studies for Mesothelioma are looking for participants at sites in and around Washington (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Long Term Follow-Up of Patients With Mesothelioma and Individuals With Germline Mutations in BAP1
RecruitingObservational study
- National Institutes of Health Clinical Center, Bethesda · 7 mi away
Tissue Procurement and Natural History Study of Patients With Malignant Mesothelioma
RecruitingObservational study
- National Institutes of Health Clinical Center, Bethesda · 7 mi away
Evaluation of Cell Changes in Blood and Tissue in Cancers of the Lung, Esophagus and Lung Lining
RecruitingObservational study
- National Institutes of Health Clinical Center, Bethesda · 7 mi away
Anti-Mesothelin TNaive/SCM hYP218 (TNhYP218) CAR T Cells in Participants With Mesothelin-Expressing Solid Tumors Including Mesothelioma
RecruitingPhase 1
- National Institutes of Health Clinical Center, Bethesda · 7 mi away
Prospective Evaluation of High Resolution Dual Energy Computed Tomographic Imaging, Noninvasive (Liquid) Biopsies, and Minimally Invasive Surgical Surveillance for Early Detection of Mesotheliomas in Patients With BAP1 Tumor Predisposition Syndrome
RecruitingObservational studyHealthy volunteers welcome
- National Institutes of Health Clinical Center, Bethesda · 7 mi away
A Study of IDE892 as Monotherapy and Combination in MTAP-deleted Advanced Solid Tumors
RecruitingPhase 1
- Johns Hopkins Sibley Memorial Hospital, Washington D.C.
Decitabine/Cedazuridine (INQOVI), an Oral DNA Demethylating Agent, in Subjects With BAP1 Cancer Predisposition Syndrome and Subclinical, Early-Stage Mesothelioma
RecruitingPhase 2
- National Institutes of Health Clinical Center, Bethesda · 7 mi away
18F-Fibroblast Activation Protein Inhibitor ([18F]FAPI-74) PET Imaging for Cancer Detection
RecruitingPhase 2
- National Institutes of Health Clinical Center, Bethesda · 7 mi away
VMD-928 Monotherapy and in Combination With Pembrolizumab to Treat TrkA Overexpression Driven Solid Tumors or Lymphoma
RecruitingPhase 1/2
- The George Washington University Cancer Center (site 212), Washington D.C.
About Mesothelioma
Mesothelioma is a tumor of mesothelium, a tissue that lines lungs and other organs. Most people who get it have inhaled asbestos. Read the symptoms.
More about Mesothelioma on MedlinePlus
Mesothelioma trials in other cities
- Houston, TX15 studies
- New York City, NY10 studies
- Chicago, IL9 studies
- Boston, MA8 studies
- Nashville, TN8 studies
- Los Angeles, CA6 studies
- Arlington, VA6 studies
- Pittsburgh, PA6 studies
- Philadelphia, PA6 studies
- Seattle, WA6 studies
- Edison, NJ5 studies
- Rochester, MN5 studies
Other studies in Washington
- Cancer (all types)58 studies
- Non-Small Cell Lung Cancer55 studies
- Breast Cancer46 studies
- Metastatic Cancer43 studies
- Lung Cancer41 studies
- Prostate Cancer38 studies
- Obesity33 studies
- Colorectal Cancer29 studies
- Cardiovascular Disease28 studies
- Bladder Cancer26 studies
- Acute Myeloid Leukemia24 studies
- Ovarian Cancer23 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.